Fig. 1: Participant flow.

Purple boxes and arrows indicate the number and flow of qualifying prodrome events treated with ubrogepant. Gray boxes and arrows indicate the number and flow of qualifying prodrome events treated with placebo. mITT, modified intention-to-treat.